Small Molecutle Drug Development for Cancer Treatment: Can-Fite (NYSE: CANF) Presents at GCFF Jun10
Can-Fite #BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company. Novel therapeutic approach – unique technology …
source